SPIMACO Pharmaceutical plant announced today on tadawul the appointment of a new CEO Mr. Fahd Bn Ibrahim Al Khalaf as of 1/1/2014.
“Mr. Fahd Al Khalaf who holds a bachelor degree from King Saud University KSA majoring in managerial science; has held many positions in SPIMACO since 1987 of which the last position was Vise CEO for marketing and sales” the company stated on tadawul.
It is noteworthy that the Board has appointed Mr. Fahd Al Khalaf as an acting CEO since 1/1/2013 after the resignation of the previous CEO Dr. Hussein Ghannam on 31/12/2012 up on personal reasons.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}